Edwards Lifesciences Corporation
EW
$85.28
-$1.90-2.18%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.26% | 14.67% | 11.89% | 6.23% | 9.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.26% | 14.67% | 11.89% | 6.23% | 9.43% |
| Cost of Revenue | 17.39% | 31.30% | 25.01% | 5.12% | 16.41% |
| Gross Profit | 12.16% | 10.66% | 8.58% | 6.53% | 7.70% |
| SG&A Expenses | 22.37% | 22.12% | 12.18% | 8.71% | 18.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 37.00% | -155.80% | -- | -- | 87.10% |
| Total Operating Expenses | 16.06% | 17.49% | 10.71% | 3.17% | 40.87% |
| Operating Income | 5.11% | 7.81% | 15.03% | 14.53% | -33.71% |
| Income Before Tax | -76.83% | -13.51% | 4.22% | 16.89% | 6.24% |
| Income Tax Expenses | -41.91% | 37.84% | 221.50% | 51.84% | 32.26% |
| Earnings from Continuing Operations | -81.39% | -19.28% | -7.72% | 11.91% | 3.57% |
| Earnings from Discontinued Operations | -31.30% | -100.07% | -540.00% | -127.59% | 7.38% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.00% | -42.86% | 30.77% | 77.78% | 550.00% |
| Net Income | -76.35% | -90.52% | -9.04% | 1.73% | 4.24% |
| EBIT | 5.11% | 7.81% | 15.03% | 14.53% | -33.71% |
| EBITDA | 4.56% | 11.42% | 13.23% | 12.64% | -30.49% |
| EPS Basic | -75.97% | -90.32% | -6.71% | 4.29% | 6.97% |
| Normalized Basic EPS | 25.49% | 1.64% | 4.75% | 15.99% | -29.27% |
| EPS Diluted | -76.64% | -90.34% | -7.54% | 4.22% | 7.08% |
| Normalized Diluted EPS | 25.35% | 1.62% | 4.99% | 16.31% | -29.16% |
| Average Basic Shares Outstanding | -1.59% | -2.09% | -2.51% | -2.44% | -2.54% |
| Average Diluted Shares Outstanding | -1.47% | -2.07% | -2.71% | -2.70% | -2.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |